Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-02CUE3Power of Attorney for Viola Mong MeehanMEDIUM
This filing details a Power of Attorney granted by Viola Mong Meehan, a director of Cue Biopharma, Inc., to Colin Sandercock and Michael Meluzio. The attorneys-in-fact are authorized to act on Ms. Meehan's behalf regarding SEC filings, including executing and submitting Forms 3, 4, 5, Schedules 13D and 13G, and Forms 1...
Micro CapBiotechnology
2026-06-02ACHV3Form 3 Filing for Jeffrey S. Farrow - Officer/Director ChangeMEDIUM
This filing is an initial report (Form 3) for Jeffrey S. Farrow, an insider of ACHIEVE LIFE SCIENCES, INC. The report indicates that Mr. Farrow, who holds a director position, currently beneficially owns no securities in the company. The filing was signed on May 29, 2026. Additionally, an exhibit (EX-24) provides a Lim...
Small CapBiotechnology
2026-06-02Cue Biopharma, Inc.3Power of Attorney for Viola Mong MeehanDuplicateMEDIUM
This filing details a Power of Attorney granted by Viola Mong Meehan, a director of Cue Biopharma, Inc., to Colin Sandercock and Michael Meluzio. The attorneys-in-fact are authorized to act on Ms. Meehan's behalf regarding SEC filings, including executing and submitting Forms 3, 4, 5, Schedules 13D and 13G, and Forms 1...
Micro CapBiotechnology